FOXA1 inhibits prostate cancer neuroendocrine differentiation

Neuroendocrine prostate cancer (NEPC) has increasingly become a clinical challenge. The mechanisms by which neuroendocrine (NE) cells arises from prostate adenocarcinoma cells are poorly understood. FOXA1 is a transcription factor of the forkhead family that is required for prostate epithelial diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung, Jin, Hongjian, Zhao, Jonathan C., Yang, Yeqing A., Li, Yinan, Yang, Ximing, Dong, Xuesen, Yu, Jindan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509480/
https://www.ncbi.nlm.nih.gov/pubmed/28319070
http://dx.doi.org/10.1038/onc.2017.50

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509480/
https://www.ncbi.nlm.nih.gov/pubmed/28319070
http://dx.doi.org/10.1038/onc.2017.50

Ejemplares similares